Wellnex Life Ltd ( (AU:WNX) ) has provided an announcement.
Wellnex Life Ltd announced the issuance of new shares as part of an agreement to extend the payment of deferred consideration for Pain Away. A total of 480,770 shares have been issued, with an additional 403,226 shares to be issued by March 21, 2025. This move is expected to impact the company’s financial operations by managing its obligations and potentially strengthening its market position.
More about Wellnex Life Ltd
Wellnex Life Ltd operates in the health and wellness industry, focusing on providing innovative health solutions. The company is involved in the production and distribution of health products, with a market focus on enhancing the well-being of its consumers.
YTD Price Performance: -7.78%
Average Trading Volume: 220
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €12.95M
See more insights into WNX stock on TipRanks’ Stock Analysis page.